1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Allogeneic Bone Marrow Transplantation: new trials by email Literature Review of Allogeneic Bone Marrow Transplantation trials Research Report on Allogeneic Bone Marrow Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MAGIC Ruxolitinib for aGVHD Ruxolitinib, Methylprednisolone - Acute Graft-versus-host Disease, Allogeneic Bone Marrow Transplantation | Phase 2 | Recruiting | John Levine | 98 | 2025-05-14 | 2026-03-23 |
| Pediatric GVHD Low Risk Steroid Taper Trial Prednisone - Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation | Phase 2 | Completed | John Levine | 50 | 2022-10-20 | 2026-06-03 |
Methylprednisolone (1) · Methylprednisolone Acetate (1) · Methylprednisolone Hemisuccinate (1) · Prednisone (1) · ruxolitinib (1)
John Levine (2)
United States (2) · Canada (1)
John E Levine, MD, MS (1) · John Levine, MD, MS (1) · Muna Qayed, MD, MS (1)
P01CA039542 (1)